GLP-1 / GIP Dual Agonist

Tirzepatide

Tirzepatide dark amber peptide research vial
99.6% Purity
HPLC/MS VerifiedWeight & MetabolicRank #01

Apex of metabolic research - the dual-incretin standard.

Tirzepatide is a dual GLP-1 and GIP receptor agonist representing the current global standard for metabolic and weight-management research. Synthesized via solid-phase Fmoc chemistry and purified by reverse-phase HPLC. Available in 5mg, 15mg, and 30mg research-grade lyophilized vials.

Spec

5mg / 15mg / 30mg - Lyophilized

Mass

5.04-30.12 mg

Purity

99.6%

Mechanism (in vitro)

Co-activates GLP-1R and GIPR pathways modulating incretin response and hepatic glucose output in vitro.

Reconstitution

Reconstitute with 2 mL bacteriostatic water for a 2.5-15 mg/mL working concentration depending on vial size.

Storage

Store lyophilized at -20 deg C. Once reconstituted, refrigerate at 2-8 deg C and use within 28 days.

Select SKU

Price · Per Vial

$16.00

5mg

View Cart
Back to Catalog

Research & Operations

Frequently Asked Questions

Clinical-grade answers to the questions that matter most in advanced research procurement.